XML 33 R18.htm IDEA: XBRL DOCUMENT
v3.20.4

Accounts Payable and Accrued Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2020
Payables And Accruals [Abstract] |
Accounts Payable and Accrued Liabilities | Note 10—Accounts payable and accrued liabilities:
| December 31, |
| 2019 |  |  | 2020 |
| (In millions) |
Accounts payable: |  |  |  |  |  |  |
Kronos | $ | 137.2 |  |  | $ | 111.0 |
CompX |  | 2.5 |  |  |  | 2.6 |
BMI/LandWell |  | 3.7 |  |  |  | 3.6 |
NL |  | .9 |  |  |  | - |
Other |  | .4 |  |  |  | .4 |
Total | $ | 144.7 |  |  | $ | 117.6 |
Current accrued liabilities: |  |  |  |  |  |  |
Employee benefits | $ | 30.6 |  |  | $ | 37.5 |
Operating lease liabilities |  | 6.2 |  |  |  | 6.7 |
Accrued sales discounts and rebates |  | 33.7 |  |  |  | 30.2 |
Deferred income |  | 10.3 |  |  |  | 20.1 |
Environmental remediation and related costs |  | 4.5 |  |  |  | 3.4 |
Interest |  | 5.2 |  |  |  | 5.7 |
Other |  | 40.0 |  |  |  | 39.4 |
Total | $ | 130.5 |  |  | $ | 143.0 |
Noncurrent accrued liabilities: |  |  |  |  |  |  |
Other postretirement benefits | $ | 10.5 |  |  | $ | 10.8 |
Operating lease liabilities |  | 22.2 |  |  |  | 18.8 |
Reserve for uncertain tax positions |  | 13.6 |  |  |  | 6.8 |
Deferred income |  | 47.4 |  |  |  | 58.9 |
Employee benefits |  | 6.0 |  |  |  | 6.2 |
Insurance claims and expenses |  | 11.0 |  |  |  | 39.3 |
Deferred payment obligation |  | 9.9 |  |  |  | 1.3 |
Accrued development costs |  | 8.3 |  |  |  | 24.6 |
Other |  | 8.2 |  |  |  | 7.8 |
Total | $ | 137.1 |  |  | $ | 174.5 |
The risks associated with certain of our accrued insurance claims and expenses have been reinsured, and the related IBNR receivables are recognized as noncurrent assets to the extent the related liability is classified as a noncurrent liability. See Note 7. Our reserve for uncertain tax positions is discussed in Note 14. In 2013 and in conjunction with the acquisition of a controlling interest of our Real Estate Management and Development Segment, we issued a face value $11.1 million deferred payment obligation owed to NERT that bears interest at 3% per annum, commencing in December 2023, and is collateralized by the BMI and LandWell interests acquired. The deferred payment obligation has no specified maturity date. We are required to make repayments on the deferred payment obligation, in specified amounts, whenever we receive distributions from BMI and LandWell, and we may make voluntary repayments on the deferred payment obligation at any time, in each case without any penalty, but in any case only after our promissory note payable to NERT (discussed in Note 9) has been repaid in full. For financial reporting purposes, the obligation was recorded at its acquisition date present value using a 3% discount rate from December 2023 (when it becomes interest bearing at 3%). We made repayments of $9.6 million during 2020 under the terms of the obligation and recognized an accretion loss of $.8 million on the early repayment. In 2021 we fully repaid the remaining $1.5 million face value outstanding under the obligation.

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration